Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization.
Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization.
复制标题
DOI:
10.1038/ncomms7565
复制
发表时间:
2015-04-10
影响因子:
16.6
通讯作者:
Seder, Robert A.
中科院分区:
文献类型:
--
作者:
Francica, Joseph R.;Sheng, Zizhang;Zhang, Zhenhai;Nishimura, Yoshiaki;Shingai, Masashi;Ramesh, Akshaya;Keele, Brandon F.;Schmidt, Stephen D.;Flynn, Barbara J.;Darko, Sam;Lynch, Rebecca M.;Yamamoto, Takuya;Matus-Nicodemos, Rodrigo;Wolinsky, David;Nason, Martha;Valiante, Nicholas M.;Malyala, Padma;De Gregorio, Ennio;Barnett, Susan W.;Singh, Manmohan;O'Hagan, Derek T.;Koup, Richard A.;Mascola, John R.;Martin, Malcolm A.;Kepler, Thomas B.;Douek, Daniel C.;Shapiro, Lawrence;Seder, Robert A.
Developing predictive animal models to assess how candidate vaccines and infection influence the ontogenies of Envelope (Env)-specific antibodies is critical for the development of an HIV vaccine. Here we use two nonhuman primate models to compare the roles of antigen persistence, diversity and innate immunity. We perform longitudinal analyses of HIV Env-specific B-cell receptor responses to SHIVAD8 infection and Env protein vaccination with eight different adjuvants. A subset of the SHIVAD8-infected animals with higher viral loads and greater Env diversity show increased neutralization associated with increasing somatic hypermutation (SHM) levels over time. The use of adjuvants results in increased ELISA titres but does not affect the mean SHM levels or CDR H3 lengths. Our study shows how the ontogeny of Env-specific B cells can be tracked, and provides insights into the requirements for developing neutralizing antibodies that should facilitate translation to human vaccine studies. HIV vaccine development will be facilitated by having animal models that are predictive for translation to humans. Here, the authors use two nonhuman primate models to compare the effects of natural infection and different adjuvants on antigen persistence, diversity and humoral immunity.
登录
查看更多内容
影响因子:
64.8
作者:
Huang J;Ofek G;Laub L;Louder MK;Doria-Rose NA;Longo NS;Imamichi H;Bailer RT;Chakrabarti B;Sharma SK;Alam SM;Wang T;Yang Y;Zhang B;Migueles SA;Wyatt R;Haynes BF;Kwong PD;Mascola JR;Connors M
通讯作者:
Connors M
影响因子:
1.8
作者:
Ketloy, Chutitorn;Engering, Anneke;Ruxrungtham, Kiat
通讯作者:
Ruxrungtham, Kiat
影响因子:
3.7
作者:
Briney BS;Willis JR;Crowe JE Jr
通讯作者:
Crowe JE Jr
影响因子:
14.9
作者:
Giudicelli, Veronique;Duroux, Patrice;Ginestoux, Chantal;Folch, Geraldine;Jabado-Michaloud, Joumana;Chaume, Denys;Lefranc, Marie-Paule
通讯作者:
Lefranc, Marie-Paule
影响因子:
56.9
作者:
Gibbs, Richard A.;Rogers, Jeffrey;Zwieg, Ann S.
通讯作者:
Zwieg, Ann S.